D1000 Varejo stock faces lower expansion plan after Q3 profit drop
Published on 11/16/2026 at 02:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSExpansion Plan Meets Softer Profit
- Adjusted net income fell year on year while adjusted EBITDA was broadly stable.
- Management lowered its 2026 opening and remodeling outlook and cut planned investment.
- The pharmacy chain ended September with 320 stores across three Brazilian markets.
D1000 Varejo reported weaker profitability alongside continued sales growth in the third quarter. The pharmacy retailer announced adjusted net income of 9.4 million Brazilian real for the period ended September 30, down 24% from a year earlier, according to Reuters in a report published Friday, November 13.
Gross revenue increased 7% to 728.7 million Brazilian real. Adjusted EBITDA edged up 0.1% to 30.6 million Brazilian real, while the adjusted EBITDA margin declined from 4.5% to 4.2%. The result leaves sales growth dependent on network expansion as profitability remains sensitive to operating costs and the mix of products sold.
Lower Store Expansion Outlook
Management reduced its 2026 plan to open 31 stores from 40 previously. The target for remodels and expansions fell to nine from 10, while planned investment for those initiatives was cut to about 120 million Brazilian real from 135 million Brazilian real.
The company is prioritizing four larger commercial sites in Rio de Janeiro. It also discontinued the monitoring of its previous long-term projection for 260 to 280 new stores through 2028 while reassessing the expansion plan.
Pharmacy Retailer In Brazil
D1000 Varejo operates the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário pharmacy brands. Its network serves customers in Rio de Janeiro, the Federal District and Mato Grosso in Brazil.
The company ended September with 320 stores after opening 23 locations and completing six remodels or expansions during the first nine months of 2026. It also closed two units during that period, keeping the focus on selected locations and capital allocation.
D1000 Varejo At A Glance
- Company: D1000 Varejo Farma Participacoes S.A.
- Business: Pharmacy retail
- Third-quarter gross revenue: 728.7 million Brazilian real
- Third-quarter adjusted net income: 9.4 million Brazilian real
- Stores at September 30: 320
Brazil's broader equity market provides the relevant home-market context for D1000 Varejo through the Bovespa market environment.
